Not Signed In - ISIS 301012 Reduces Atherosclerotic Plaques In Animal Models
Sat, 29 Apr 2006 06:00 AM EST
... IsisPharmaceuticals, Inc. (Nasdaq: ISIS) today announced results of a studyshowing that ISIS 301012 reduced atherosclerotic plaques, apoB-100, andcirculating inflammatory cytokines in an animal model of atherosclerosis.These data support a growing body of evidence demonstrating that ISIS301012 has the potential to treat patients with coronary artery disease... click link for more info. ...
Related Topics
- Service Animals
- Animal Research
- Pets and Pet Health
- Bites and Stings
- Disease models
- Quarantine
- Animal Sports
- Animal-Related Diseases
- Service Animals/animal Assistants
- Understanding Medical Research
- Welfare
- Adoption
- Eleuthero
- Fluorouracil
- Cardiovascular Diseases And Disorders
- Vascular Disease
- Coronary Artery Disease
- Coronary Artery Diseases
- Genetics & Genomics
- Homeopathy
email this page
print this page
bookmark this page
feedback on this page
